Piper Sandler raises Becton Dickinson stock target to $280
Piper Sandler's analysts increased the price target for Becton Dickinson (NYSE:BDX) shares to $280 from $275, while maintaining an Overweight rating. The adjustment follows a period of underperformance for Becton Dickinson stock,
Which Is a Better Investment, Becton, Dickinson and Company or Intuitive Surgical, Inc. Stock?
Learn more about whether Becton, Dickinson and Company or Intuitive Surgical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Piper Sandler Boosts Becton, Dickinson and Company (NYSE:BDX) Price Target to $280.00
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its target price hoisted by analysts at Piper Sandler from $275.00 to $280.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical instruments supplier’s stock.
Becton Dickinson price target raised to $280 from $275 at Piper Sandler
Piper Sandler raised the firm’s price target on Becton Dickinson (BDX) to $280 from $275 and keeps an Overweight rating on the shares. The firm
Becton Dickinson and Co (BDX) Stock: Analyzing Its Quiet Power
Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $243.45 which represents a slight increase of $2.98 or 1.24% from the prior close of $240.47. The stock opened at $239 and touched a low of $238.
bovnews1d
Becton Dickinson and Co (BDX) Stock Posted a Gross Margin of 45.36% Over the Past Year: Is This Justifiable?
Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $249.08 which represents a slight increase of $0.38 or 0.15% from the prior close of $248.7. The stock opened at $248.68 and ...
Becton Dickinson approves additional 10M shares repurchase program
Becton, Dickinson and Company announced it repurchased $750M in BD stock to date in FY25. In addition, the board has authorized the company to ...
Becton Dickinson & Co. stock outperforms competitors on strong trading day
This was the stock's third consecutive day of gains.
Masimo taps Becton Dickinson executive Katie Szyman as CEO
Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after ...
Becton, Dickinson and Company (NYSE:BDX) Approves Stock Repurchase Plan
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) announced that its board has authorized a share buyback program on ...
BDX stock touches 52-week high at $248.61 amid market optimism
In a notable performance, Becton Dickinson and Co. (NYSE:BDX) stock achieved a 52-week high, reaching a price level of ...
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, ...
Zawya3d
BD to showcase medtech innovations and signature programmes at Arab Health 2025
Company will spotlight sustainable solutions to enhance patient safety, workforce well-being, and care delivery efficiency ...